Navigation Links
MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
Date:9/11/2008

GAITHERSBURG, Md. and TOKYO, Sept. 11 /PRNewswire/ -- MedImmune, the global biologics unit of AstraZeneca, and SBI Biotech Co., Ltd, a subsidiary of SBI Holdings, Inc., announced today that they have entered into a licensing and collaboration agreement to develop and commercialize SBI Biotech's anti-ILT7 protein for the potential treatment of systemic lupus erythematosus (SLE) and other autoimmune diseases. MedImmune has global rights to any resulting product candidates and will be responsible for preclinical and clinical development, as well as all future development, manufacturing, sales and marketing activities.

"It's an honor to work with Ken-ichi Arai, founder of SBI Biotech and one of Japan's leading scientists. We look forward to collaborating with him and his organization as we develop potential new treatments for autoimmune diseases such as SLE," said Anthony J. Coyle, Ph.D., vice president, research, respiratory, inflammation and autoimmunity. "As an innovative company dedicated to making a difference for patients, MedImmune will continue to seek out research and development initiatives that may address some of society's critical unmet medical needs."

Under the terms of the agreement, MedImmune is to provide SBI Biotech with an undisclosed upfront payment, milestone payments and royalties on future marketed products. SBI Biotech has granted MedImmune an exclusive license to research, develop and commercialize products that target the ILT7 protein. In addition, MedImmune will have the option to license additional targets resulting from SBI Biotech's research activities.

"We are pleased to collaborate with MedImmune, a company with strong capabilities to develop therapeutic antibodies including expertise in humanization and large-scale production. MedImmune is an excellent company and this agreement facilitates the research and development of an anti-ILT7 antibody," said Ken-ichi Arai, M.D. and Ph.D., president & CEO, SBI Biotech.
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
2. MedImmune Expands Scientific and Engineering Leadership
3. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
4. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
5. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
6. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
7. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
8. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
9. Further Acquisition for Schofield Media Group LLC
10. FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Go Further by Giving FDA Authority Over Tobacco Products
11. Area Women Gather in Milford on July 10 to Further the Mission of Womens Caring Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Francisco, September 15, 2014Prostate cancer patients who received ... quality of life, as well as bladder and ... after RT, according to research presented today at ... Annual Meeting. Additionally, results indicate that parallel quality ... who receive different regimens of HPFX RT. , ...
(Date:9/16/2014)... who have had children (parous women) appear to ... breast cancer, the subtype that carries a higher ... of African ancestry. A similar relationship was ... between childbearing and increased risk of estrogen receptor-negative ... the women who had never breastfed. These findings, ...
(Date:9/16/2014)... better predict a man,s risk of getting prostate cancer ... largest-ever analysis of the cancer,s genetic biomarkers, reported in ... Health and Biomedical Innovation,s Dr Jyotsna Batra and Distinguished ... the large consortia of research hubs around the world, ... markers in 80,000 men. , "It,s the largest analysis ...
(Date:9/16/2014)... Definitive Healthcare , the ... providers, is pleased to announce the release of ... now available for subscription, features detailed hospital profiles ... affiliations. , The Canadian database spans Canada’s ten ... over 750 hospitals. Each hospital profile provides ...
(Date:9/16/2014)... 16, 2014 Gary F. Locke, the ... has selected Worldwide Speakers Group for exclusive representation of ... of Commerce and Governor of Washington, Locke is widely ... U.S.-China relations, global expansion, and business growth. , “Gary ... and how to grow an organization’s global presence in ...
Breaking Medicine News(10 mins):Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 2Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 3Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2Health News:New gene research helps pinpoint prostate cancer risk 2Health News:Canadian Hospital Database Now Offered by Definitive Healthcare 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2
... of Canadian surgeons got a shock when the patient they ... ,Describing the case in the Lancet, lead doctor Dr. Alana ... team was startled to discover green blood flowing in the ... 42-year-old man was being operated upon to prevent his condition-compartment ...
... able to uncover the fate of the lost colony with ... than 100 people settled on the Roanoke Island in ... and historical narratives have gathered around 168 surnames that could ... the English trying to colonize the new world. ...
... of Buffalo, for the first time in its 23 years of ... . The festival attracts tens of thousand of people from all ... vendor's menu must meet standards on fat, salt and cholesterol. ... have mango sorbet and smoked chicken sandwiches along with the hot ...
... appear healthy, making it difficult to detect outbreaks of the ... Monday. ,Indonesia, the country worst hit by ... H5N1 outbreaks across its vast archipelago. ,"From our ... bird flu have not been showing the usual symptoms," Memed ...
... Hong Kong on Monday warned the public to stop ... industrial chemical. The customs department said samples contained ... was discovered in exports of Chinese toothpaste to Panama. ... toothpaste imports and Singapore has banned three Chinese brands. ...
... body representing the vast majority of Britain's casinos ... government plans to shake-up the country's gambling ... persuade the London-based court that Labour's policy to ... Vegas-style "super-casino," was treating existing gaming establishments with ...
Cached Medicine News:Health News:DNA Link to a Lost Colony 2Health News:Healthier Options at the Buffalo Food Fest 2
(Date:9/16/2014)... , Sept. 16, 2014  Formex, ... manufacturing, announced that Mr. Greg Weilersbacher joined Formex ... 25, 2014. Greg Weilersbacher ... experience with focused expertise in Quality Assurance, ... Mr. Weilersbacher brings to Formex a ...
(Date:9/16/2014)... , Sept. 16, 2014 On September 25 ... exhibition focusing on medical design and manufacturing - MEDTEC ... Shanghai World Expo Exhibition & Convention Center, bringing together ... and regions to showcase their latest medical-grade raw materials, ... only one week remaining for free visitor pre-registration to ...
(Date:9/16/2014)... , Sept. 16, 2014 CorMedix ... focused on developing and commercializing therapeutic products for ... infectious diseases, announces the amendment and restatement of ... preferred stock and related warrants, as well as ... stock and warrant financing, to remove anti-dilution, price ...
Breaking Medicine Technology:Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... 2011 Hospira, Inc. (NYSE: HSP ... technologies, today reported results for the third quarter ended Sept. ... and adjusted* diluted earnings per share were $0.66. (Adjusted* measures ... release and the attached schedules.) "As we indicated ...
... NEW YORK, Oct. 26, 2011 Reportlinker.com ... is available in its catalogue: ... Worldwide, 2009 to 2015 ... study has 484 pages, 235 tables and ...
Cached Medicine Technology:Hospira Reports Third-Quarter 2011 Results 2Hospira Reports Third-Quarter 2011 Results 3Hospira Reports Third-Quarter 2011 Results 4Hospira Reports Third-Quarter 2011 Results 5Hospira Reports Third-Quarter 2011 Results 6Hospira Reports Third-Quarter 2011 Results 7Hospira Reports Third-Quarter 2011 Results 8Hospira Reports Third-Quarter 2011 Results 9Hospira Reports Third-Quarter 2011 Results 10Hospira Reports Third-Quarter 2011 Results 11Hospira Reports Third-Quarter 2011 Results 12Hospira Reports Third-Quarter 2011 Results 13Hospira Reports Third-Quarter 2011 Results 14Hospira Reports Third-Quarter 2011 Results 15Hospira Reports Third-Quarter 2011 Results 16Hospira Reports Third-Quarter 2011 Results 17Hospira Reports Third-Quarter 2011 Results 18Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 2Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 3Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 4Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 5Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 6Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 7Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 8Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 9Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 10Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 11Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 12Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 13Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 14Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 15Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 16Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 17Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 18Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 19
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: